We report five 
INTRODUCTION
No single operative treatment is optimal for variceal hemorrhage arising from portal hypertension. Standard portacaval shunts reliably control recurrent variceal hemorrhage, but may be accompanied by an unacceptably high risk of post-shunt encephalopathy [1, 2] . Further, a later attempt at liver transplantation may be complicated by the adhesions and anatomic distortion resulting from the prior right upper quadrant operation [3] [4] [5] . Selective shunts avoid the hilum of the liver but have a higher risk of variceal rebleeding [6] and may result in portal vein thrombosis [7] . Occasionally, diffuse splanchnic venous thrombosis [8, 9] [13] . At least 10% of such patients will suffer portal vein thrombosis [7] , thereby markedly complicating subsequent liver transplantation. Further, when compared to standard portacaval shunts in properly-designed prospective randomized trials [14] , selective shunts do not provide definitive protection against post-shunt neurologic complications, especially in that majority of Western patients who are alcoholics [15] .
Other operative procedures to prevent variceal bleeding, most notably various forms of esophagogastric devascularization as popularized by Sugiura [16] , have had excellent results in Japan, but these have not been confirmed either in Western Europe or in North America.
Use of IMV for portal decompression has been reported sporadically in the past [17] [18] [19] [20] -most commonly in patients is whom diffuse splanchnic venous thrombosis [8, 9] interdicted standard shunt procedures, or in patients in whom prior splenectomy prevented the performance of distal splenorenal shunt [20] . These indications remain relevant, but we have resurrected the IMV shunt because of two newer additional considerations development of the concept of partial portal decompression and the maturation of liver transplantation as a clinically feasible management of patients with liver disease and variceal hemorrhage.
A body of recent experimental [21] and clinical [22] [23] [24] data suggest that, in comparison to total shunts, procedures which only partially decompress the portal system may result in a lesser risk of post-shunt liver failure and neurologic deterioration. Some investigators suggest that this beneficial effect results from continued prograde portal flow [24] , consonant with the "selectivity" principle originally characterized by Warren [12] . Other studies, however, suggest that the protective effect of partial portal decompression is due to diminished intestinal neurotoxin absorption in the presence of residual mesenteric venous hypertension [21, 22] . Regardless, shunts which only partially decompress the portal system appear to result in a lower risk of post-shun[ morbidity and mortality [22] [23] [24] . This principle has been applied to the concept of transjugular intrahepatic portacaval shunting (TIPS), a nonsurgical transcatheter technique in which a 10mm Hg post-shunt gradient between portal vein and supra-hepatic inferior vena cava is considered optimal [26] .
The increasing availibility of liver transplantation to treat end-stage liver disease means that certain variceal bleeders treated by shunt operations may later be transplant candidates [3] . While prior performance of a standard portacaval shunt is no longer an absolute contraindication to liver transplantation [25] , the scarring and anatomic distortion from such procedures undoubtedly complicate the performance of subsequent liver replacement [3] [4] [5] . Consequently, the recommendation has been made that any such patient who might later require liver transplantation should undergo either mesocaval [27] or distal splenorenal shunts [4, 5] . Because the former procedure has a substantial rate of graft thrombosis and recur-rent variceal bleeding [28] , and the latter procedure is technically taxing [13] and has multiple contraindications [29] , an alternative shunt option would be very helpful. In certain patients TIPS may be an option: however, this procedure is not durable and may have substantial complications [30, 31] , sometimes necessitating operative portal decompression [31] . We view the IMV shunt as a rational alternative in such patients.
An important feature favoring the use of the IMV for portal decompression is its technical ease. Because of the proximity of the IMV and the left renal vein the IMV shunt may be the most technically straightforward of all portal decompressive procedures. The IMV dilates in portal hypertension [17] , frequently to 5-6mm in diameter and even more in certain conditions of diffuse splanchnic venous thrombosis where it may remain the only patent mesenteric outflow vessel [17] [18] [19] . Second, the procedure is performed entirely on the left side of the mesentery, leaving the right upper quadrant inviolateuseful if future orthotopic liver transplantation is contemplated. Third, because it is an exemplary "small-stoma" shunt, it only partially decompresses the portal system and should confer maximal protection against post-shunt encephalopathy [21] [22] [23] [24] . Finally (particularly if the procedure is performed as an inferior mesocaval anastomosis, as in our Patient #4) excellent angiographic access to the coronary veins for subsequent embolization may be possible [32] .
While longer follow-up of a larger group of patients is required to discern whether use Our group's current view is that endoscopic therapy is the primary treatment of choice for acute bleeding varices. We agree with the shift that is occurring to variceal banding or a combination of banding and sclerotherapy from the previously widely used pure sclerotherapy techniques [1] . We define failures as patients who have two further bleeds after endoscopic management during a single hospital admission for acute variceal bleeding. We currently submit such patients to an emergency TIPS procedure. It should be noted that this is rarely undertaken, because the percentage of patients failing endoscopic therapy in our institution is currently very low [2] . If a patient with diffuse splanchnic venous thrombosis, including portal vein thrombosis was to fail endoscopic therapy, then the authors' suggestion of a surgical inferior mesenteric vein shunt, if this vein is patent and enlarged, seems reasonable.
